BACKGROUND/AIM: Lower body weight in later life has been shown to be associated with dementia. However, abdominal fat distribution under conditions of mild cognitive impairment (MCI) and the possible involvement of leptin and adiponectin in MCI have not been fully investigated. METHODS: We analyzed 517 middle-aged-to-elderly community-dwelling persons. Abdominal subcutaneous fat and visceral fat areas were determined using computed tomography, and plasma leptin and adiponectin concentrations were measured in fasting samples. MCI was assessed using the Japanese version of the MCI screening method. RESULTS: In men, the abdominal subcutaneous fat area was significantly lower in participants with MCI than in those with normal cognitive function [median (interquartile range): 107.4 (85.9, 133.1) cm² vs. 136.4 (93.1, 161.4) cm²; p = 0.002]. Logistic regression analyses with confounding factors including age and abdominal subcutaneous fat area showed that a 10 mg/l increase in plasma adiponectin had a protective effect against the development of MCI in men (odds ratio: 0.46; 95% CI: 0.20-0.97; p = 0.041). In contrast, MCI was not found to be associated with abdominal fat area or adipose-derived hormones in women. CONCLUSION: Reduced amounts of subcutaneous fat and low levels of plasma adiponectin were found to be associated with MCI in men.
BACKGROUND/AIM: Lower body weight in later life has been shown to be associated with dementia. However, abdominal fat distribution under conditions of mild cognitive impairment (MCI) and the possible involvement of leptin and adiponectin in MCI have not been fully investigated. METHODS: We analyzed 517 middle-aged-to-elderly community-dwelling persons. Abdominal subcutaneous fat and visceral fat areas were determined using computed tomography, and plasma leptin and adiponectin concentrations were measured in fasting samples. MCI was assessed using the Japanese version of the MCI screening method. RESULTS: In men, the abdominal subcutaneous fat area was significantly lower in participants with MCI than in those with normal cognitive function [median (interquartile range): 107.4 (85.9, 133.1) cm² vs. 136.4 (93.1, 161.4) cm²; p = 0.002]. Logistic regression analyses with confounding factors including age and abdominal subcutaneous fat area showed that a 10 mg/l increase in plasma adiponectin had a protective effect against the development of MCI in men (odds ratio: 0.46; 95% CI: 0.20-0.97; p = 0.041). In contrast, MCI was not found to be associated with abdominal fat area or adipose-derived hormones in women. CONCLUSION: Reduced amounts of subcutaneous fat and low levels of plasma adiponectin were found to be associated with MCI in men.
Authors: Kirby G Parker; Seth T Lirette; David S Deardorff; Lawrence F Bielak; Patricia A Peyser; J Jeffrey Carr; James G Terry; Myriam Fornage; Emelia J Benjamin; Stephen T Turner; Thomas H Mosley; Michael E Griswold; B Gwen Windham Journal: J Gerontol A Biol Sci Med Sci Date: 2018-03-14 Impact factor: 6.053
Authors: Jordan E Lake; Quynh T Vo; Lisa P Jacobson; Ned Sacktor; Eric N Miller; Wendy S Post; James T Becker; Frank J Palella; Ann Ragin; Eileen Martin; Cynthia A Munro; Todd T Brown Journal: Antivir Ther Date: 2015-03-26
Authors: Adina Zeki Al Hazzouri; Mary N Haan; Rachel A Whitmer; Kristine Yaffe; John Neuhaus Journal: Dement Geriatr Cogn Disord Date: 2012-07-17 Impact factor: 2.959
Authors: Jordan E Lake; Mikhail Popov; Wendy S Post; Frank J Palella; Ned Sacktor; Eric N Miller; Todd T Brown; James T Becker Journal: J Neurovirol Date: 2016-12-15 Impact factor: 2.643
Authors: Thomas M van Himbergen; Alexa S Beiser; Masumi Ai; Sudha Seshadri; Seiko Otokozawa; Rhoda Au; Nuntakorn Thongtang; Philip A Wolf; Ernst J Schaefer Journal: Arch Neurol Date: 2012-05